{"database":"biostudies-literature","file_versions":[],"scores":null,"additional":{"submitter":["Patterson Gentile C"],"funding":["National Institute of Neurological Disorders and Stroke","Pfizer","NINDS NIH HHS","National Institute of Neurological Disorders and Stroke (NINDS)"],"pagination":["1217-1229"],"full_dataset_link":["https://www.ebi.ac.uk/biostudies/studies/S-EPMC11560481"],"repository":["biostudies-literature"],"omics_type":["Unknown"],"volume":["64(10)"],"pubmed_abstract":["<h4>Objectives</h4>We used Cluster Analysis of Migraine-associated Symptoms (CAMS) to critically evaluate current International Classification of Headache Disorders-Third Edition (ICHD-3) migraine-associated symptoms criteria.<h4>Background</h4>Diagnostic criteria play a central role in guiding clinical trial inclusion, and therefore available treatments. Migraine and tension-type headaches (TTH) are differentiated in ICHD-3 by many headache characteristics, including associated symptoms. A diagnosis of probable migraine indicates some but not all features of migraine are met. Photophobia and phonophobia, or nausea and/or vomiting, are required to meet a diagnosis of migraine; however, CAMS-a model that describes associated symptoms across youth with headache-indicates that a broader range"],"journal":["Headache"],"pubmed_title":["A critical appraisal of the International Classification of Headache Disorders migraine diagnostic criteria based on a retrospective multicenter cross-sectional headache registry study in youth."],"pmcid":["PMC11560481"],"funding_grant_id":["K23 NS124986","K23NS102521","K23NS124986","K23 NS102521"],"pubmed_authors":["Szperka CL","Hershey AD","Patterson Gentile C"],"additional_accession":[]},"is_claimable":false,"name":"A critical appraisal of the International Classification of Headache Disorders migraine diagnostic criteria based on a retrospective multicenter cross-sectional headache registry study in youth.","description":"<h4>Objectives</h4>We used Cluster Analysis of Migraine-associated Symptoms (CAMS) to critically evaluate current International Classification of Headache Disorders-Third Edition (ICHD-3) migraine-associated symptoms criteria.<h4>Background</h4>Diagnostic criteria play a central role in guiding clinical trial inclusion, and therefore available treatments. Migraine and tension-type headaches (TTH) are differentiated in ICHD-3 by many headache characteristics, including associated symptoms. A diagnosis of probable migraine indicates some but not all features of migraine are met. Photophobia and phonophobia, or nausea and/or vomiting, are required to meet a diagnosis of migraine; however, CAMS-a model that describes associated symptoms across youth with headache-indicates that a broader range","dates":{"release":"2024-01-01T00:00:00Z","publication":"2024 Nov-Dec","modification":"2026-06-05T07:17:24.352Z","creation":"2026-05-14T03:08:35.04Z"},"accession":"S-EPMC11560481","cross_references":{"pubmed":["39463026"],"doi":["10.1111/head.14858"]}}